Skip to main content
CHYM
NASDAQ Finance

Chime Financial Confirms Strong 2025 Performance with Audited Results, Reports Positive Adjusted EBITDA

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$22.31
Mkt Cap
$8.656B
52W Low
$16.17
52W High
$44.94
Market data snapshot near publication time

summarizeSummary

Chime Financial's 2025 annual report confirms strong revenue and member growth, with Adjusted EBITDA turning positive. A large net loss was primarily due to IPO-related stock compensation, and the company initiated a significant share repurchase program.


check_boxKey Events

  • Full Year 2025 Revenue Growth

    Revenue increased 31% year-over-year to $2.19 billion, driven by growth in active members and new product launches.

  • Adjusted EBITDA Turns Positive

    The company achieved a positive Adjusted EBITDA of $126.6 million in 2025, a significant improvement from a loss in the prior year, reflecting enhanced operational performance.

  • Net Loss Driven by IPO-Related Stock Compensation

    A net loss of $1.01 billion was reported, largely due to $1.09 billion in non-cash stock-based compensation expense from equity awards vesting upon the June 2025 IPO.

  • Strong Member and Purchase Volume Growth

    Active members grew 19% to 9.5 million, and purchase volume increased 16% to $133.7 billion, indicating robust user engagement.


auto_awesomeAnalysis

Chime Financial's 2025 annual report confirms robust operational performance, with revenue increasing 31% to $2.19 billion and active members growing 19% to 9.5 million. A significant highlight is the shift to a positive Adjusted EBITDA of $126.6 million, indicating improved underlying profitability and operational efficiency. While the company reported a net loss of $1.01 billion, this was primarily driven by a substantial $1.09 billion in non-cash stock-based compensation expense related to the vesting of equity awards upon its June 2025 IPO. The company also initiated a $200 million share repurchase program in November 2025, having already repurchased $77.5 million by year-end, signaling management confidence. Investors should note the 85% increase in transaction and risk losses, primarily from liquidity products and isolated fraud incidents, which warrants continued monitoring.

At the time of this filing, CHYM was trading at $22.31 on NASDAQ in the Finance sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $16.17 to $44.94. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CHYM - Latest Insights

CHYM
Apr 17, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CHYM
Mar 05, 2026, 7:16 PM EST
Filing Type: 10-K
Importance Score:
8
CHYM
Feb 25, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
9